The question comes up in almost every formula conversation with parents I talk to. It usually arrives with some real context behind it, the 2022 Abbott Sturgis Cronobacter event, the 2025 ByHeart botulism recall, or a neighbor who imports HiPP because "the European stuff is cleaner." The answer is more nuanced than "yes" or "no", and the nuance is what actually helps parents choose.
How the two regulatory systems actually differ
Two prescriptive frameworks shape what ends up in a bottle, one US, one EU, and they draw the line in different places. The FDA vs EFSA comparison pillar walks through this in detail. Short version: the EU framework pushes harder on what must be in the formula; the US framework pushes harder on what happens when something goes wrong.
EU Regulation 2016/127 mandates lactose as the predominant carbohydrate in Stage 1 formula (not optional), mandates DHA at 20-50 mg per 100 kcal (since 2020), and sets tighter upper bounds on several micronutrients. FDA 21 CFR Part 107 sets minimums for 30 nutrients but is more permissive on carbohydrate sources (corn syrup solids are allowed) and does not mandate DHA.
On the enforcement side, the relationship reverses. FDA has mandatory recall authority under the Food Safety Modernization Act, inspects domestic manufacturing facilities at a known cadence, and maintains a public registration database. EU enforcement runs through member-state authorities (SKAL in the Netherlands, Bundesministerium in Germany) with EU-level coordination through RASFF, less centralized, less transparent for a US parent trying to look up compliance history.
Where "safety" actually shows up in the data
Both systems have produced serious recall events in the last decade. Abbott's Sturgis Cronobacter contamination in February 2022 affected Similac, Alimentum, and EleCare across multiple states; by May that year the US was in a national formula shortage. See the Abbott 2022 recall aftermath pillar for the full timeline. In November 2025, ByHeart issued a Class I nationwide recall covering every batch ever produced after 51 infant botulism hospitalizations traced to Clostridium botulinum in its organic whole milk powder supply.
European manufacturers have had recall events too, smaller in scale but not zero. Nestlé recalled French-produced formulas in 2017-2018 over Salmonella. Lactalis pulled batches across 83 countries in the same period. None of these events scaled to the market-disruption level of Abbott 2022 in the US, but that's partly a function of supply chain structure (fewer single points of failure in Europe) and partly regulatory coincidence.
What parents actually care about: and what changes with choice
For a parent choosing between HiPP Dutch Stage 1 and Bobbie Original, the safety question lands on three practical dimensions.
First, composition. HiPP Dutch uses Metafolin (the bioactive folate form) and adds GOS prebiotic plus L. fermentum probiotic. Bobbie uses folic acid, adds no probiotic, has no palm oil. Different optimization targets, both compliant, neither demonstrably safer than the other for healthy term infants.
Second, import logistics. HiPP Dutch arrives via Organic's Best Shop under FDA enforcement discretion, a stable legal pathway but one that carries 5-10 day shipping and occasional customs delays. Bobbie arrives next-day from Target or Amazon. In a supply shock, "next-day domestic" is a real safety feature.
Third, recall traceability. FDA-registered products (Bobbie, Similac, Enfamil, ByHeart) show up in the FDA recall database if something happens. EU products (HiPP, Holle, Kendamil) typically surface via manufacturer notifications and RASFF; slower for a US parent to catch. This is why the changelog tracks both channels.
When "European is safer" actually holds up
For two specific scenarios the case for European formula has real support. Parents who know they or their partner carry an MTHFR gene variant benefit from Metafolin over folic acid because the bioactive form bypasses enzymatic conversion. Parents avoiding corn-syrup-solids as the primary carbohydrate find that EU Reg 2016/127 makes this the default rather than an opt-in.
For everything else, contamination risk, manufacturing rigor, recall responsiveness, the meaningful comparison is not "EU vs US" but "which specific brand, at which specific manufacturing facility, with which specific recall history." That's what each brand hub and SKU page in the Atlas tracks.
What you should actually do
Start with your pediatrician if there's any clinical concern (CMPA, reflux, preterm feeding). For a healthy term baby without concerns, the honest frame is: pick a brand whose composition philosophy matches what you weight, whose supply chain fits your logistics, and whose recall history you've actually reviewed. "EU" and "US" are not safety grades. They're regulatory regions with different emphases.
Related reading
- HiPP Dutch Stage 1 vs Bobbie Original, the concrete EU-vs-US product choice
- FDA vs EFSA standards compared, full regulatory side-by-side
- How to buy European formula in the US, the legal import pathway
- US formula recall history, cross-brand timeline of recall events
This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.